Powering Faster, More Precise Antibody Discovery
The AbD Beacon Selectâ„¢ system revolutionizes antibody discovery (AbD) by combining cutting-edge optofluidics and proprietary workflows.
This state-of-the-art instrument leverages a 2-chip single-cell optofluidic design that significantly reduces the time and cost needed to identify the most promising antibody lead candidates.
By harnessing the power of Opto® B Discovery workflows, the Beacon Select system accelerates the discovery and testing process, making it more efficient and accessible beyond the reach of traditional methods.
Proteomic Barcoding Technology
Product Suite
- 3 Proteomic Barcoding Systems
- 6 Proteomic Solutions
- Proven Protocols & Training Modules
- Webinars, Videos & Literature
Optofluidic Technology
Product Suite
- 6 Optofluidic Instruments
- 6 Workflows
- Proven Protocols & Technical Support
- Webinars, Videos & Literature
Explore the Power of the Beacon Select for Antibody Discovery Research
of Antibody Discovery
ACCELERATE
The Beacon Select system can drastically reduce your AbD timelines and downstream costs by allowing you to bypass less promising candidates and devote your resources to only the most promising ones.
It achieves this by functionally screening thousands of B cells in a single day and identifying the best candidates within hours, a process that traditionally takes months.
Cell-binding Assay
CUSTOMIZE
Unlock the potential of personalized assays with Beacon Select. Customize for both soluble and membrane-bound targets, integrate with Opto B Discovery, and fast-track your B cell screening from months to hours. Leverage our technology for a swift, customized approach to antibody discovery.
SCREEN AND RECOVER
The power of the Beacon Select lies in optofluidics, a revolutionary blend of optics and nanofluidics.
The OptoSelect® chips replace traditional well plates, each housing thousands of NanoPen® chambers, where deposited cells grow and are characterized via our proprietary PhenomeX assays.
Our technology enables you to recover lead molecules and re-express over 1,000 antibodies in only 1 week without gene synthesis and cloning.
Simply fill out the form to request a chat with one of our experts.
In a 30-minute call, we’ll be able to answer your questions, show you how the Beacon system can accelerate your AbD research, and share the most relevant datasheets & case studies for your research.